Michel Goldman

Insulin Needs after CD3-Antibody Therapy in New-Onset Type 1 Diabetes

Bart Keymeulen, Evy Vandemeulebroucke, Anette G. Ziegler et al. · New England Journal of Medicine · 2005 · 1.1K citations · Full text

Medicine, Endocrinology, Immunology +17

Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia.

Catherine Gérard, Catherine Bruyns, Arnaud Marchant et al. · The Journal of Experimental Medicine · 1993 · 800 citations · Full text

Veterinary Medicine, Immunology, Pharmacology +17

Development of a cross-platform biomarker signature to detect renal transplant tolerance in humans

Pervinder Sagoo, Esperanza Perucha, Birgit Sawitzki et al. · Journal of Clinical Investigation · 2010 · 517 citations · Full text

Life Sciences, Immunology, Nephrology +17

Bacterial lipopolysaccharide stimulates the production of cytokines and the expression of costimulatory molecules by human peripheral blood dendritic cells: evidence for a soluble CD14-dependent pathway

Valérie Verhasselt, Christel Buelens, Fabienne Willems et al. · The Journal of Immunology · 1997 · 427 citations · Full text

Life Sciences, Immunology, Microbiology +17

Role of interleukin‐4 and interleukin‐10 in murine collagen‐induced arthritis. Protective effect of interleukin‐4 and interleukin‐10 treatment on cartilage destruction

Leo A. B. Joosten, Erik Lubberts, Patrick Durez et al. · Arthritis & Rheumatism · 1997 · 399 citations

Veterinary Medicine, Immunology, Pathobiology +17